BPGbio regularly participates in conferences throughout the year to present our research and development to peers. Many of these presentation posters are available below.

Available posters are listed in their respective category.

 

BPM31510 for GBM, Pancreatic Cancer & Primary CoQ10 Deficiency

MitoCon 2026 Poster In-vivo CoQ4 PDSS2

MitoCon 2026 Poster CoQ10 Deficiency Clinical

SNO 2025 Poster – Stanford GBM

SNO 2025 Poster – BPM31510 GBM Phase 2

SNO 2025 – Poster – Translation Clinical-Preclinical – BPM31510 Warburg GBM

MMTD 2025 – Poster – BPM31510 CoQ10 Deficiency

MMTD 2025 – Poster – BPM31510 Increases CoQ Pool

SITC 2025 – BPM31510 IO Metabolism

ASHG 2025 – CoQ10 Deficiency

ESMO 2025 – BPM31510 GBM Ph1&2 Interim PD

ESMO 2025 – BPM31510 GBM Phase 2

ASMS 2025 Poster – CoQ10 Quinomics

Mito Trans 2025 Poster_COQ10 Quinomics

AACR 2025 – Poster – BPM31510 C6 Glioma Quinone

AACR 2025 Poster – BPM31510 Ferroptosis Independent

AACR 2025 Poster – BPM31510 GBM Phase 2

AACR 2025 Poster – BPM31510 TME

AACR 2025 Poster – CoQ10

AACR 2025 Poster – Project Survival

ASCO GI 2025 Poster – Project Survival

MitoCon 2024 Poster – Employment of Spatial Omics and Quinomics Technologies for the Advancement of Mitochondrial Targeted Therapeutics

Poster AACR 2024 BPM31510 Tumor microenvironment via mitochondrial-mediated ROS production

ESMO 2024 Poster – Quinomics BPM31510

ESMO 2024 Poster – BPM31510 GBM Phase 2

Poster 101_ASCO GI 2024 – Multiomics BPM31510 Ph2 PDAC

Poster GBM Ph2 Trial-In-Progress Update at SNO 2023

Poster 74_ESMO 2019 – PD in Phase 1 Clinical Trial Design PDF

 

Alzheimer’s Disease, Huntington’s Disease, & Parkinson’s Disease

SfN 2025 Poster – Htt Assays

SfN 2025 Poster – Living Brain

SfN 2025 Poster – Lyso-Auto

SfN 2025 – Nanosymposium Presentation – Proteinopathies

CHDI 2025 Poster 2025_UBE2K Huntingtin

SfN24 poster – UBE2K Huntington’s Drug Target

SfN24 Poster – Alzheimer’s Disease Biomarker

 

Protein Degradation

ASMS 2025 Poster – UBE2 Family TPD

 

UBE2M for Anticancer Therapy

Poster AACR 2024 In charge: Targeting neddylation of UBE2M for anticancer therapy

 

BRG399 Anticancer Drug

AACR 2025 Poster – BRG399 IO

SITC 2024 Poster – BRG399 GBM  

SNO 2024 Poster – BRG399 GBM

Poster AACR 2024 Application of a deep learning based drug sensitivity prediction model on a novel anticancer drug

Poster AACR 2023 Development of a Novel Oral Microtubule Targeting Agent with Pan-Cancer Activity (BRG399)

 

Prostate Cancer Dx

Poster AACR 2024 Diagnostic assessment of Filamin A (FLNA) as a serum biomarker for identification of benign prostatic hyperplasia vs aggressive prostate cancer in a prospective Mexican cohort

Poster AACR 2023 Serum Filamin A is a Prognostic Biomarker for Screening Benign Prostatic Hyperplasia vs Prostate Cancer in Caucasian and African American Men